NCT02857309View on ClinicalTrials.gov

Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure

NATerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 15, 2018

Study Completion Date

February 15, 2018

Conditions
Heart Failure
Interventions
DEVICE

OPTIMIZER

The OPTIMIZER System delivers non-excitatory cardiac contractility modulation (CCM) signals to the heart that are intended to influence myocardial properties in patients with chronic heart failure. The system has no pacemaker or implantable cardioverter-defibrillator (ICD) functions.

DRUG

Optimal medical therapy

OMT using standard heart failure (HF) drugs

Trial Locations (8)

Unknown

Universitätsklinik Innere Medizin, Graz

Universtitätsklinikum; Medizinische Klinik I, Aachen

Universitätsklinikum; Kardiologie im Herzzentrum, Cologne

Helios Klinikum; 3. Medizinische Klinik, Erfurt

Albertinen Krankenhaus, Hamburg

Universität Leipzig; Abteilung für Kardiologie und Angiologie, Leipzig

4th Military Hospital, Wroclaw

Karolinska University Hospital, Stockholm

Sponsors

Lead Sponsor

Impulse Dynamics
All Listed Sponsors
lead

Impulse Dynamics

INDUSTRY

NCT02857309 - Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure | Biotech Hunter | Biotech Hunter